Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Understanding your own response pattern requires patience and consistent tracking
Results announced in December 2025 confirmed the Phase 2 findings at a longer timepoint (Lilly Press Release, Dec 2025): The 28.7% weight loss at 68 weeks exceeds both semaglutide (~15% in STEP trials) and tirzepatide (~22.5% in SURMOUNT trials) at similar timepoints
[5] Each formulation has distinct dosing schedules, with some administered daily and others weekly
Absorption of lisdexamfetamine dimesylate and its hydrolysis to active d-amphetamine
Symptoms include confusion, dizziness, and excessive sweating
US$ 20.43
US$ 25.68
US$ 29.03
US$ 24.40
US$ 27.56
